Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking

G Aleppo, IB Hirsch, CG Parkin, J McGill… - Diabetes technology …, 2023 - liebertpub.com
Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring
(CGM) in individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) who are treated …

Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: a systematic review and network meta‐analysis of randomized controlled trials

J Lu, Z Ying, P Wang, M Fu, C Han… - Diabetes, Obesity and …, 2024 - Wiley Online Library
Aims The aim of this study was to assess the efficacy of continuous glucose monitoring
(CGM) versus self‐monitoring of blood glucose (SMBG) in maintaining glycaemic control …

Emerging diabetes technologies: continuous glucose monitors/artificial pancreases

AM Almurashi, E Rodriguez, SK Garg - Journal of the Indian Institute of …, 2023 - Springer
Over the past decade there have been many advances in diabetes technologies, such as
continuous glucose monitors (CGM CGM: A device that measures glucose values in the …

[HTML][HTML] Continuous glucose monitoring in a healthy population: understanding the post-prandial glycemic response in individuals without diabetes mellitus

PRE Jarvis, JL Cardin, PM Nisevich-Bede, JP McCarter - Metabolism, 2023 - Elsevier
Continuous glucose monitoring has become a common adjunct in the management of
Diabetes Mellitus. However, there has been a recent trend among individuals without …

Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis

AL Carlson, TD Daniel, A DeSantis… - BMJ Open Diabetes …, 2022 - drc.bmj.com
Introduction Evidence supporting use of continuous glucose monitoring in type 2 diabetes
treated with basal insulin is unclear. This real-world study aimed to assess the impact on …

In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure

KH Chun, J Oh, CJ Lee, JJ Park, SE Lee… - Cardiovascular …, 2022 - Springer
Background High glycemic variability (GV) is a poor prognostic marker in cardiovascular
diseases. We aimed to investigate the association of GV with all-cause mortality in patients …

Blood glucose level time series forecasting: nested deep ensemble learning lag fusion

H Khadem, H Nemat, J Elliott, M Benaissa - Bioengineering, 2023 - mdpi.com
Blood glucose level prediction is a critical aspect of diabetes management. It enables
individuals to make informed decisions about their insulin dosing, diet, and physical activity …

Comparisons of fifth-, sixth-, and seventh-generation continuous glucose monitoring systems

JB Welsh, S Psavko, X Zhang… - Journal of Diabetes …, 2024 - journals.sagepub.com
Background: Between-system differences for continuous glucose monitoring (CGM) devices
have important clinical consequences. Purpose: Here we review attributes of Dexcom's fifth …

Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review

A Aggarwal, S Pathak, R Goyal - Diabetes Research and Clinical Practice, 2022 - Elsevier
Objective Poor glycemic management increases the risk of cardiac, microvascular, and other
complications. Therefore, timely assessment and control of glycemic levels is paramount in …

[HTML][HTML] Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management

APS Kong, S Lim, SH Yoo, L Ji, L Chen, Y Bao… - Diabetes research and …, 2023 - Elsevier
Glucose monitoring has evolved from self-monitoring of blood glucose to glycated
hemoglobin, and the latest continuous glucose monitoring (CGM). A key challenge to …